INSM - INSMED Inc


149.88
2.880   1.922%

Share volume: 2,002,655
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%

$147.00
2.88
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-09-2024 08-08-2024 10-31-2024 02-20-2025 05-08-2025 08-07-2025 10-30-2025 02-19-2026
Total revenue 75.500 M 90.340 M 93.425 M 104.442 M 92.823 M 107.415 M 142.342 M 263.843 M
Cost of revenue 17.457 M 20.964 M 21.170 M 26.151 M 21.278 M 28.075 M 29.365 M 44.220 M
Gross profit 58.043 M 69.376 M 72.255 M 78.291 M 71.545 M 79.340 M 112.977 M 219.623 M
    19.53% 4.15% 8.35% -8.62% 10.90% 42.40% 94.40%  
Operating expenses 214.185 M 253.317 M 269.739 M 322.242 M 300.122 M 331.953 M 372.791 M 467.394 M
Selling general and admin 93.102 M 106.569 M 118.930 M 142.515 M 147.545 M 154.763 M 186.376 M 212.483 M
Research and development 121.083 M 146.748 M 150.809 M 179.727 M 152.577 M 177.190 M 186.415 M 254.911 M
Total expenses 203.548 M 358.280 M 285.684 M 308.705 M 319.685 M 392.216 M 478.982 M 539.371 M
    76.02% -20.26% 8.06% 3.56% 22.69% 22.12% 12.61%  
Operating income -145.505 M -288.904 M -213.429 M -230.414 M -248.140 M -312.876 M -366.005 M -319.748 M
Ebit -144.243 M -289.173 M -215.438 M -229.369 M -248.008 M -312.423 M -366.608 M -321.571 M
Pretax income -156.502 M -299.771 M -219.510 M -234.282 M -255.671 M -320.443 M -368.701 M -326.934 M
    91.54% -26.77% 6.73% 9.13% 25.33% 15.06% -11.33%  
Income tax 589.000 K 838.000 K 1.014 M 1.266 M 912.000 K 1.243 M 1.320 M 1.551 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -314.182 M -300.609 M -220.524 M -78.457 M -256.583 M -321.686 M -370.021 M -328.485 M
    4.32% 26.64% 64.42% -227.04% -25.37% -15.03% 11.23%